"10.1371_journal.pone.0009166","plos one","2010-02-11T00:00:00Z","Enrico Domenici; David R Will√©; Federica Tozzi; Inga Prokopenko; Sam Miller; Astrid McKeown; Claire Brittain; Dan Rujescu; Ina Giegling; Christoph W Turck; Florian Holsboer; Edward T Bullmore; Lefkos Middleton; Emilio Merlo-Pich; Robert C Alexander; Pierandrea Muglia","Neurosciences Centre of Excellence in Drug Discovery, GlaxoSmithKline R&D, Verona, Italy; Discovery Statistics Europe, GlaxoSmithKline R&D, Harlow, United Kingdom; Quantitative Sciences, GlaxoSmithKline R&D, Verona, Italy; Genetics Division, Drug Discovery, GlaxoSmithKline R&D, Verona, Italy; GSK Clinical Units, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany; Max-Planck Institute of Psychiatry, Munich, Germany; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; Genetics Division, Drug Discovery, GlaxoSmithKline R&D, Greenford, Middlesex, United Kingdom","Conceived and designed the experiments: ED FT IP LTM EMP PM. Analyzed the data: ED DRW IP SM AM CB CWT EB EMP RCA PM. Contributed reagents/materials/analysis tools: AM DR IG FH. Wrote the paper: ED DRW PM. Critically reviewed the manuscript: FT DR IG CWT FH EB LTM EMP RCA. Contributed text to the final manuscript: SM CB.","ED, DW, FT, SM, AMK, EMP and RA are currently full-time employees at GSK. ETB is employed part-time at GSK and part-time at the University of Cambridge. The authors agree with the PLoS ONE data and materials sharing policy.","2010","02","Enrico Domenici","ED",16,TRUE,6,NA,11,3,TRUE,TRUE,FALSE,0,NA,FALSE
